心脏沙尔科毒症;为心力衰竭专家提供最新信息
1Division of Cardiology, University of Ottawa Heart Institute, University of Ottawa, Faculty of Medicine, Tier 1 Clinical Research Chair in Cardiac Electrophysiology, Ottawa, ON, Canada.
Current opinion in cardiology
|January 30, 2025
概括
心脏型硬化症 (CS) 影响约5%的型硬化症患者,导致心律失常和心力衰竭. 改进的诊断和先进的治疗方法,包括ICD,已经显著改善了CS患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 临床表现的心脏肉类瘤 (CS) 影响约5%的肉类瘤患者.
- 呈现包括显著的心律失常和无法解释的心力衰竭,这可能是最初的表现.
- 孤立的CS概念受到辩论,一些病例与遗传性心肌病相关.
研究的目的:
- 介绍有关心脏沙尔科毒症 (CS) 流行病学,表现,诊断和治疗的当代数据.
- 专注于左心室 (LV) 功能改变治疗后和标准和先进疗法的结果.
- 为心力衰竭专家提供相关的见解.
主要方法:
- 审查关于CS的当代数据.
- 讨论诊断工具,包括心磁共振成像 (CMR) 用于纤维化和FDG-positron发射断层扫描 (FDG-PET) 用于炎症.
- 分析治疗策略,包括免疫抑制,心力衰竭药物和设备治疗.
主要成果:
- 心脏磁共振成像 (CMR) 首选用于纤维化;FDG-PET识别活跃的炎症并指导免疫抑制.
- 管理涉及免疫抑制,标准心力衰竭药物和植入式心脏转动器除器 (ICDs) 的高风险患者.
- 心脏移植和心室辅助装置是末期心力衰竭的选择; 长期移植结果是有利的.
结论:
- 在过去的二十年中,CS的结果有了显著的改善.
- 早期诊断,先进的心力衰竭治疗和战略性ICD使用有助于改善预后.
- 左心室功能障碍仍然是CS的关键预后因素.
更多相关视频
07:09A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
1.7K
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.4K
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Heart Failure Drugs: Inotropic Agents
507
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
507
01:22Heart Failure Drugs: β-Blockers
311
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
311
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
375
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
375
01:22Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
01:26Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K